Company Filing History:
Years Active: 2021-2023
Title: Juergen Hahn: Innovator in Multivariate Analysis and Imaging Technologies
Introduction
Juergen Hahn is a notable inventor based in Ballston Lake, NY (US). He holds 2 patents that showcase his contributions to the fields of multivariate analysis and imaging technologies. His work has significant implications for the assessment and treatment of autism spectrum disorder (ASD) and advancements in medical imaging.
Latest Patents
Hahn's latest patents include innovative methods for utilizing multivariate analysis to assess treatment approaches for ASD. His first patent focuses on employing Fisher discriminant analysis on data sets from typically developing individuals and those with ASD. This model classifies individuals based on their metabolic profiles, predicting treatment effectiveness based on biochemical measurements.
The second patent involves systems and methods for integrating tomographic image reconstruction and radiomics using neural networks. This technology enhances the accuracy of computed tomography (CT) screenings and diagnoses by mapping raw tomographic data directly to diagnostic findings through machine learning frameworks. The end-to-end network trained on this data can produce potential diagnoses based on extracted features, applicable to various imaging modalities.
Career Highlights
Throughout his career, Juergen Hahn has worked with prestigious institutions such as Rensselaer Polytechnic Institute and Arizona State University. His research has contributed to significant advancements in understanding and treating ASD, as well as improving diagnostic processes in medical imaging.
Collaborations
Hahn has collaborated with notable professionals in his field, including Uwe Kruger and Ge Wang. These partnerships have further enriched his research and innovations, leading to impactful developments in his areas of expertise.
Conclusion
Juergen Hahn's work exemplifies the intersection of innovative research and practical applications in healthcare. His patents reflect a commitment to improving treatment methodologies and diagnostic accuracy, making a lasting impact in the fields of autism research and medical imaging.